1. European Pharmacopoeia 7.5. ed., 2012; 01/20012:1000 General notices. European Directorate for the Quality of Medicines and Healthcare, Strassbourg, France, 2010–2013.
2. Drug excipients;Kalasz;Curr. Med. Chem.,2006
3. EMA, ICH Topic Q3C (R4) Impurities: Guideline for Residual Solvents Step 5, CPMP/ICH/283/95, 2009. 〈http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002674.pdf〉.
4. EMA, Guideline on excipients in the dossier for application for marketing authorisation of a medicinal product. EMEA/CHMP/QWP/396951/2006, 2006. 〈http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003428.pdf〉.
5. Handbook of Pharmaceutical Excipients;Rowe,2003